D-0769-2021 Class II Ongoing
FDA drug recall D-0769-2021 was initiated by Teligent Pharma, Inc. on Jul 29, 2021 and is designated Class II. Reason for recall: Defective container: possibility for lack of seal integrity. The recall status is ongoing. Affected quantity: 7488 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 1, 2021
- Initiation Date
- Jul 29, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7488 bottles
Product description
Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc. Buena, NJ 08310, NDC 52565-027-59
Reason for recall
Defective container: possibility for lack of seal integrity.
Distribution pattern
USA Nationwide
Code information
Lot #: 14892, Exp 1/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0769-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026